A bus, believed to carry U.S. citizen Michael Taylor, suspected of helping former Nissan Motor Chairman Carlos Ghosn to escape to Lebanon, leaves Narita airport, following Taylors' extradition to Japanese prosecutors, in Chiba, Japan, March 2, 2021. REUTERS/Kim Kyung-Hoon

Two buses, believed to carry U.S. citizens Michael Taylor and his son Peter Taylor, who are suspected of helping former Nissan Motor Chairman Carlos Ghosn to escape to Lebanon, leave Narita airport, following Taylors' extradition to Japanese prosecutors, in Chiba, Japan, March 2, 2021. REUTERS/Kim Kyung-Hoon

A man, believed to be U.S. citizen Michael Taylor, suspected of helping former Nissan Motor Chairman Carlos Ghosn to escape to Lebanon, is escorted by Japanese officers upon his arrival at Narita airport, following Taylors' extradition to Japanese prosecutors, in Chiba, Japan, March 2, 2021. REUTERS/Kim Kyung-Hoon

A man, believed to be U.S. citizen Peter Taylor, suspected of helping former Nissan Motor Chairman Carlos Ghosn to escape to Lebanon, is escorted by Japanese officers upon his arrival at Narita airport, following Taylors' extradition to Japanese prosecutors, in Chiba, Japan, March 2, 2021. REUTERS/Kim Kyung-Hoon

A man, believed to be U.S. citizen Michael Taylor, suspected of helping former Nissan Motor Chairman Carlos Ghosn to escape to Lebanon, is escorted by Japanese officers upon his arrival at Narita airport, following Taylors' extradition to Japanese prosecutors, in Chiba, Japan, March 2, 2021. REUTERS/Kim Kyung-Hoon

Japanese officers get prepared to escort U.S. citizens Michael Taylor and his son Peter Taylor, suspected of helping former Nissan Motor Chairman Carlos Ghosn to escape to Lebanon, upon their arrival at Narita airport, following their extradition to Japanese Prosecutors, in Chiba, Japan, March 2, 2021. REUTERS/Kim Kyung-Hoon

A plane, believed to carry U.S. citizens Michael Taylor and his son Peter Taylor, who are suspected of helping former Nissan Motor Chairman Carlos Ghosn to escape to Lebanon, arrive at Narita airport, following Taylors' extradition to Japanese prosecutors, in Chiba, Japan, March 2, 2021. REUTERS/Kim Kyung-Hoon

Myanmar citizens show the three-finger salute as they join Thai demonstrators during an anti-government protest in Bangkok, Thailand February 28, 2021. REUTERS/Soe Zeya Tun

Myanmar citizens shout as they join Thai demonstrators during an anti-government protest in Bangkok, Thailand February 28, 2021. REUTERS/Soe Zeya Tun

A Myanmar citizen holds Aung San Suu Kyi portrait as he joins with Thai protesters an anti-government protest in Bangkok, Thailand February 28, 2021. REUTERS/Soe Zeya Tun

Myanmar citizens shout as they join a Thai an anti-government protest in Bangkok, Thailand February 28, 2021. REUTERS/Soe Zeya Tun

A health worker applies the second dose of Sinovac's CoronaVac coronavirus disease (COVID-19) vaccine to an elderly citizen at Solar das Acacias nursing home, in Guarulho near Sao Paulo, Brazil February 26, 2021. REUTERS/Carla Carniel

A health worker applies the second dose of Sinovac's CoronaVac coronavirus disease (COVID-19) vaccine to an elderly citizen at Solar das Acacias nursing home, in Guarulho near Sao Paulo, Brazil February 26, 2021. REUTERS/Carla Carniel

A health worker applies the second dose of Sinovac's CoronaVac coronavirus disease (COVID-19) vaccine to an elderly citizen at Solar das Acacias nursing home, in Guarulho near Sao Paulo, Brazil February 26, 2021. REUTERS/Carla Carniel

A health worker prepares to apply the second dose of Sinovac's CoronaVac coronavirus disease (COVID-19) vaccine to an elderly citizen at Solar das Acacias nursing home, in Guarulho near Sao Paulo, Brazil February 26, 2021. REUTERS/Carla Carniel

A health worker applies the second dose of Sinovac's CoronaVac coronavirus disease (COVID-19) vaccine to an elderly citizen at Solar das Acacias nursing home, in Guarulho near Sao Paulo, Brazil February 26, 2021. REUTERS/Carla Carniel TPX IMAGES OF THE DAY

A health worker applies the second dose of Sinovac's CoronaVac coronavirus disease (COVID-19) vaccine to an elderly citizen at Solar das Acacias nursing home, in Guarulho near Sao Paulo, Brazil February 26, 2021. REUTERS/Carla Carniel

A health worker applies the second dose of Sinovac's CoronaVac coronavirus disease (COVID-19) vaccine to an elderly citizen at Solar das Acacias nursing home, in Guarulho near Sao Paulo, Brazil February 26, 2021. REUTERS/Carla Carniel

An elderly citizen holds a cardboard, that reads: "Second dose. Vaccinated!" after receiving her second dose of Sinovac's CoronaVac coronavirus disease (COVID-19) vaccine at Solar das Acacias nursing home, in Guarulho near Sao Paulo, Brazil February 26, 2021. REUTERS/Carla Carniel

A health worker applies the second dose of Sinovac's CoronaVac coronavirus disease (COVID-19) vaccine to an elderly citizen at Solar das Acacias nursing home, in Guarulho near Sao Paulo, Brazil February 26, 2021. REUTERS/Carla Carniel

A health worker shows the Sinovac's CoronaVac coronavirus disease (COVID-19) vaccine before applying it to an elderly citizen at the Museum of the Republic at Catete Palace in Rio de Janeiro, Brazil February 25, 2021. REUTERS/Ricardo Moraes

A health worker applies a Sinovac's CoronaVac coronavirus disease (COVID-19) vaccine to an elderly citizen at the Museum of the Republic at Catete Palace in Rio de Janeiro, Brazil February 25, 2021. REUTERS/Ricardo Moraes

A health worker prepares a Sinovac's CoronaVac coronavirus disease (COVID-19) vaccine before applying it to an elderly citizen at the Museum of the Republic at Catete Palace in Rio de Janeiro, Brazil February 25, 2021. REUTERS/Ricardo Moraes

Elderly citizens arrive at the Museum of the Republic at Catete Palace to get the Sinovac's CoronaVac coronavirus disease (COVID-19) vaccine in Rio de Janeiro, Brazil February 25, 2021. REUTERS/Ricardo Moraes

A health worker applies a Sinovac's CoronaVac coronavirus disease (COVID-19) vaccine to a citizen at the Museum of the Republic at Catete Palace in Rio de Janeiro, Brazil February 25, 2021. REUTERS/Ricardo Moraes

A health worker applies a Sinovac's CoronaVac coronavirus disease (COVID-19) vaccine to an elderly citizen at the Museum of the Republic at Catete Palace in Rio de Janeiro, Brazil February 25, 2021. REUTERS/Ricardo Moraes

A health worker applies a Sinovac's CoronaVac coronavirus disease (COVID-19) vaccine to an elderly citizen at the Museum of the Republic at Catete Palace in Rio de Janeiro, Brazil February 25, 2021. REUTERS/Ricardo Moraes

Employees of the State Independent Authority of Public Revenue speak to citizens via teleconference in Athens, Greece, January 25, 2021. Picture taken January 25, 2021. REUTERS/Alkis Konstantinidis

Head of the State Independent Authority of Public Revenue George Pitsilis speaks to a citizen via teleconference in Athens, Greece, January 25, 2021. Picture taken January 25, 2021. REUTERS/Alkis Konstantinidis

Employees of the State Independent Authority of Public Revenue speak to citizens via teleconference in Athens, Greece, January 25, 2021. Picture taken January 25, 2021. REUTERS/Alkis Konstantinidis

An employee of the State Independent Authority of Public Revenue speaks to a citizen via teleconference in Athens, Greece, January 25, 2021. Picture taken January 25, 2021. REUTERS/Alkis Konstantinidis

Myanmar citizens in Thailand protest in front of Indonesia embassy Bangkok, Thailand February 23, 20121. REUTERS/Soe Zeya Tun

A girl holds a placard and a rose as she attends Myanmar citizens in Thailand protest, in front of Indonesia embassy Bangkok, Thailand February 23, 20121. REUTERS/Soe Zeya Tun

Myanmar citizens in Thailand hold plackards as they protest in front of Indonesia embassy Bangkok, Thailand February 23, 20121. REUTERS/Soe Zeya Tun

Myanmar citizens in Thailand protest in front of Indonesia embassy Bangkok, Thailand February 23, 20121. REUTERS/Soe Zeya Tun

Myanmar citizens in Thailand protest in front of Indonesia embassy Bangkok, Thailand February 23, 20121. REUTERS/Soe Zeya Tun

Journalist and citizens sit inside a court ahead of the appearance of former South African President Jacob Zuma, on charges of fraud, racketeering and money laundering at the Pietermaritzburg high court in South Africa, February 23, 2021. Themba Hadebe/Pool via REUTERS

Syringes with the Pfizer-BioNTec vaccine against coronavirus disease (COVID-19) sit on the table at the Victor Walchirk Apartments in Evanston, Illinois, U.S. February 22, 2021. REUTERS/Kamil Krzaczynski

Syringes with the Pfizer-BioNTec vaccine against coronavirus disease (COVID-19) sit on the table at the Victor Walchirk Apartments in Evanston, Illinois, U.S. February 22, 2021. REUTERS/Kamil Krzaczynski

Walgreens healthcare professional Luis S. Solano prepares a dose of the Pfizer-BioNTec vaccine against coronavirus disease (COVID-19) at the Victor Walchirk Apartments in Evanston, Illinois, U.S. February 22, 2021. REUTERS/Kamil Krzaczynski

Walgreens healthcare professional Luis S. Solano prepares a dose of the Pfizer-BioNTec vaccine against coronavirus disease (COVID-19) at the Victor Walchirk Apartments in Evanston, Illinois, U.S. February 22, 2021. REUTERS/Kamil Krzaczynski

Walgreens healthcare professional Luis S. Solano prepares a dose of the Pfizer-BioNTec vaccine against coronavirus disease (COVID-19) at the Victor Walchirk Apartments in Evanston, Illinois, U.S. February 22, 2021. REUTERS/Kamil Krzaczynski

Walgreens healthcare professional Luis S. Solano prepares a dose of the Pfizer-BioNTec vaccine against coronavirus disease (COVID-19) at the Victor Walchirk Apartments in Evanston, Illinois, U.S. February 22, 2021. REUTERS/Kamil Krzaczynski

Walgreens healthcare professionals pass to each other the Pfizer-BioNTec vaccine against coronavirus disease (COVID-19) at the Victor Walchirk Apartments in Evanston, Illinois, U.S. February 22, 2021. REUTERS/Kamil Krzaczynski

Syringes with the Pfizer-BioNTec vaccine against coronavirus disease (COVID-19) sit on the table at the Victor Walchirk Apartments in Evanston, Illinois, U.S. February 22, 2021. REUTERS/Kamil Krzaczynski

Syringes with the Pfizer-BioNTec vaccine against coronavirus disease (COVID-19) sit on the table at the Victor Walchirk Apartments in Evanston, Illinois, U.S. February 22, 2021. REUTERS/Kamil Krzaczynski

Valerie Al-Barakat (R) receives the Pfizer-BioNTech vaccine against coronavirus disease (COVID-19) from Walgreens healthcare professional Ghassan Ayyad (L) at the Victor Walchirk Apartments in Evanston, Illinois, U.S. February 22, 2021. REUTERS/Kamil Krzaczynski

Elizabeth Harris-Penick (R) receives the Pfizer-BioNTech vaccine against coronavirus disease (COVID-19) from Walgreens healthcare professional Ghassan Ayyad (L) at the Victor Walchirk Apartments in Evanston, Illinois, U.S. February 22, 2021. REUTERS/Kamil Krzaczynski

Lillie McCray (R) receives the Pfizer-BioNTech vaccine against coronavirus disease (COVID-19) from Walgreens healthcare professional Ghassan Ayyad (L) at the Victor Walchirk Apartments in Evanston, Illinois, U.S. February 22, 2021. REUTERS/Kamil Krzaczynski

Lillie McCray (R) receives the Pfizer-BioNTech vaccine against coronavirus disease (COVID-19) from Walgreens healthcare professional Ghassan Ayyad (L) at the Victor Walchirk Apartments in Evanston, Illinois, U.S. February 22, 2021. REUTERS/Kamil Krzaczynski

Walgreens healthcare professional Luis S. Solano holds a vial of the Pfizer-BioNTech vaccine against coronavirus disease (COVID-19) at the Victor Walchirk Apartments in Evanston, Illinois, U.S. February 22, 2021. REUTERS/Kamil Krzaczynski

Margie Collins (R) receives the Pfizer-BioNTech vaccine against coronavirus disease (COVID-19) from Walgreens healthcare professional Ghassan Ayyad (L) at the Victor Walchirk Apartments in Evanston, Illinois, U.S. February 22, 2021. REUTERS/Kamil Krzaczynski

Austin Clark (R) receives the Pfizer-BioNTech vaccine against coronavirus disease (COVID-19) from Walgreens healthcare professional Ghassan Ayyad (L) at the Victor Walchirk Apartments in Evanston, Illinois, U.S. February 22, 2021. REUTERS/Kamil Krzaczynski

Lorine Jefferson (L) receives the Pfizer-BioNTech vaccine against coronavirus disease (COVID-19) from Walgreens healthcare professional Ghassan Ayyad (R) at the Victor Walchirk Apartments in Evanston, Illinois, U.S. February 22, 2021. REUTERS/Kamil Krzaczynski

Cordell Reid (L) receives the Pfizer-BioNTech vaccine against coronavirus disease (COVID-19) from Walgreens healthcare professional Ghassan Ayyad (R) at the Victor Walchirk Apartments in Evanston, Illinois, U.S. February 22, 2021. REUTERS/Kamil Krzaczynski

Bruce A. McGehee (L) receives the Pfizer-BioNTech vaccine against coronavirus disease (COVID-19) from Walgreens healthcare professional Ghassan Ayyad (R) at the Victor Walchirk Apartments in Evanston, Illinois, U.S. February 22, 2021. REUTERS/Kamil Krzaczynski

Michael Nash (R) receives the Pfizer-BioNTech vaccine against coronavirus disease (COVID-19) from Walgreens healthcare professional Ghassan Ayyad (L) at the Victor Walchirk Apartments in Evanston, Illinois, U.S. February 22, 2021. REUTERS/Kamil Krzaczynski

Lashon Parker receives the Pfizer-BioNTech vaccine against coronavirus disease (COVID-19) from Walgreens healthcare professional at the Victor Walchirk Apartments in Evanston, Illinois, U.S. February 22, 2021. REUTERS/Kamil Krzaczynski

A man receives the Pfizer-BioNTech vaccine against coronavirus disease (COVID-19) from Walgreens healthcare professional Ghassan Ayyad (L) at the Victor Walchirk Apartments in Evanston, Illinois, U.S. February 22, 2021. REUTERS/Kamil Krzaczynski

Austin Clark (R) receives the Pfizer vaccine against coronavirus disease (COVID-19) from Walgreens healthcare professional Ghassan Ayyad (L) at the Victor Walchirk Apartments in Evanston, Illinois, U.S. February 22, 2021. REUTERS/Kamil Krzaczynski